Introduction
At sites of infection, monocytes are recruited from the blood and differentiate in situ into diverse macrophage (MΦ) and dendritic cell (DC) populations as part of the local innate immune response. The differentiation of monocytes into MΦ and DC can be triggered by microbial ligands that activate pattern recognition receptors, resulting in the release of cytokines that induce specific functional programmes. For example, Toll-like receptor (TLR) activation of human monocytes induces rapid differentiation into two distinct subsets: MΦ and DC, involving the up-regulation of cytokine and receptor pairs. 1 The TLR induction of interleukin-15 (IL-15) was required and also sufficient for differentiation of monocytes into MΦ, which were CD209 + and co-expressed the MΦ markers, CD14, CD16, CD64 but not the DC marker CD1b. In addition, TLR induction of granulocyte-macrophage colony-stimulating factor (GM-CSF) was required and also sufficient for differentiation of CD1b + DC; these cells co-expressed high levels of the DC markers CD1b, CD40 and CD86 but not the MΦ markers. Alternatively, NOD2-mediated induction of IL-32 was required and also sufficient to trigger a distinct DC pathway. 2 These pattern recognition receptor-and cytokine-induced MΦ and DC pathways were found to contribute to host responses against microbial infection in humans.
A key cytokine of the innate immune response to microbial infection is Interleukin-1b (IL-1b), a proinflammatory cytokine that triggers monocyte activation, inducing cytokine release and differentiation into DC. 3 IL-1b can directly trigger monocyte differentiation into CD1b + DC 3 and can act with immune complexes to induce differentiation of M2 MΦ. 4 The activation of 
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monocytes with IL-1b and TLR2/1 ligands (TLR2/1L) is transduced via a common MyD88 signalling pathway. 5 Given that TLR2/1 activation triggers the differentiation of monocytes into MΦ and DC, we hypothesized that IL1b might also trigger monocyte differentiation into specific cell types with distinct innate immune functions.
Materials and methods

Microbial ligands and cytokines
For activation of monocytes, recombinant human IL-1b (10 ng/ml, R&D Systems, Minneapolis, MN), the TLR2/ 1L, mycobacterial 19 000 molecular weight lipopeptide (1 lg/ml, EMC Microcollections, T€ ubingen, Germany), 1 recombinant human GM-CSF (1 U/ml, Genzyme, Cambridge, MA) or IL-15 (200 ng/ml, R&D Systems) was used. These reagents were all tested for endotoxin by Limulus amoebocyte lysate assay (Lonza, Basel, Switzerland) to be endotoxin free (detection limit < 0Á1 EU/ml).
Monocyte isolation and enrichment
We obtained whole blood from healthy donors (UCLA I.R.B. #92-10-591-31) with informed consent. Peripheral blood mononuclear cells were isolated using Ficoll (GE Healthcare, Little Chalfont, UK) gradient centrifugation and monocytes were further enriched using Percoll density gradient (GE Healthcare) and subsequent adherence in 1% fetal calf serum (FCS) for 2 hr. Monocyte purity was found to be > 80% as measured by CD14 expression. Cells were cultured for 2 or 3 days in RPMI-1640 and 10% FCS (Omega Scientific, Yately, UK). To purify CD209 + MΦ, cells were cultured with IL-1b or TLR2/1L for 2 days in RPMI-1640 with 10% FCS (Omega Scientific) and labelled with a magnetic microbead-coupled CD209 antibody (Miltenyi Biotec, Bergisch Gladbach, Germany). The positive population was collected using magnetic-activated cell sorting according to the manufacturer's recommendations (Miltenyi Biotec). Purity was confirmed to be > 90% by flow cytometry.
Cell surface labelling and FACS
Cell surface expression of antigenic determinants was measured using epitope-specific antibodies and cells were acquired and analysed as described elsewhere. 6 The following fluorochrome-coupled monoclonal antibodies were used: CD23, CD64, CD16, SRAI/II, MARCO, CD36, CD163, CD206, CD86, CD80, CD40, HLA-DR and CD209 (BD Pharmingen, Franklin Lakes, NJ). For detection of CD1b a monoclonal primary antibody (1 lg/ml, Bcd3.1, American Type Culture Collection, Manassass, VA) was used, followed by an IgG1-specific fluorochrome-coupled secondary antibody (Invitrogen, Carlsbad, CA).
Endocytosis and phagocytosis assays
Interleukin-1b-or TLR2/1L-derived MΦ were incubated with the following: Lucifer yellow or DiI(1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate)-labelled CuSO 4 -oxidized low-density lipoprotein (oxLDL, Intracel RP-175) or live mycobacteria, bacillus CalmetteGu erin-green fluorescent protein (BCG-GFP; gift from Dr Barry Bloom, Harvard, Cambridge, MA) as previously described. 1, 7, 8 Binding was assayed by incubating macrophages with Lucifer yellow, oxLDL or BCG-GFP at 4°. Cells were then harvested, labelled with CD209, and analysed by flow cytometry. Intracellular uptake was shown as DMFI = MFI uptake À MFI binding , where MFI is mean fluorescence intensity. Cells were then harvested, labelled with CD209, and analysed by flow cytometry.
T-cell assays
For investigation of MHC class II restricted antigen presentation to T cells, monocytes from HLA-DR-matched donors were differentiated and subsequently purified using IL-1b, TLR2/1L or GM-CSF (as described above). The CD209 + MΦ and CD1b + DC were then cultured with the MHC class II-restricted T-cell clone derived from a patient with tuberculoid leprosy (1 9 10 5 , BCD4.9) that recognized the Mycobaterium leprae GroES protein and a defined peptide spanning amino acids 28-39 in an HLA-DR15-restricted manner as described previously. Interferon-c (IFN-c) was measured by ELISA (BD Pharmingen) and proliferation was measured using [ 3 H]thymidine incorporation as described elsewhere. 10 
Results
IL-1b induces rapid differentiation of monocytes into CD209 + MΦ
To determine whether IL-1b induced monocyte differentiation into MΦ, we first performed a dose-response experiment measuring IL-1b induction of CD209. A dose-response was obtained for the induction of CD209 expression with the maximum response observed at 10 ng/ml IL-1b (see Supplementary material, Fig. S1 ), the dose selected for further experiments. The optimal concentrations for IL-15-, GM-CSF-and TLR2/1L-induced monocyte differentiation were determined previously in our laboratory. 1 We next compared the effect of IL-1b versus a synthetic TLR2/1L, the 19 000 molecular weight Mycobacterium tuberculosis-derived lipopeptide, on monocyte differentiation ( + MΦ (26%) and CD1b + DC (12Á4%) after 2 days of culture (Fig. 1b,c) . 1 Given that TLR2/1L induces CD209 + MΦ and CD1b + DC via IL-15 and GM-CSF, respectively, we compared the effect of these two cytokines on monocyte differentiation. After 2 days of culture, IL-15 induced CD209 + MΦ (37Á8%), but not CD1b + DC (2Á4%); whereas, GM-CSF induced CD1b + DC (45Á7%), but not CD209 + MΦ (5Á2%). These data indicate that IL-1b is a more potent inducer of monocyte differentiation into CD209 + MΦ than TLR2/1L.
IL-1b-induced CD209 + MΦ differ phenotypically from those induced by TLR2/1 activation Since CD209 + MΦ are induced by either IL-1b or TLR2/ 1L, we wanted to compare the phenotype of these MΦ populations according to cell surface determinants. In these experiments, we gated on the CD209 + cells when measuring other cell surface markers. The IL-1b-induced CD209 + MΦ expressed at least 1Á6-fold higher percentage positive cells and 2Á5-fold or higher MFI levels of CD16 (Fcc receptor III; FccRIII) and CD64 (FccRI) than TLR2/ 1L-induced MΦ (Fig. 2) . Furthermore, IL-1b induced at least a twofold higher percentage of cells expressing key phagocytic markers, such as the SRAI/II (scavenger receptors), MARCO (macrophage receptor with a collagenous structure), CD36 (scavenger receptor for oxLDL), CD163 (haemoglobin/haptoglobin scavenger receptor) and CD206 (MΦ mannose receptor). Furthermore, the expression levels of CD36, CD163 and CD206 were also significantly higher in IL-1b-induced versus TLR2/1L-induced MΦ. Finally, IL-1b induced about fourfold higher expression levels of the antigen presentation molecule HLA-DR compared with TLR2/1L. Therefore, our data indicate that IL-1b-induced MΦ express higher levels of cell surface proteins involved in phagocytosis and antigen presentation than TLR2/1L-induced MΦ.
IL-1b-induced CD209 + MΦ show high phagocytic activity
The high expression of markers for phagocytosis on the IL-1b-induced CD209 + MΦ suggests that these cells have a potential for phagocytic activity. To measure the potential for pinocytosis and phagocytosis, we tested differentiated MΦ for the specific uptake of Lucifer yellow, oxLDL and BCG. We also compared uptake by IL-15-derived MΦ, given that these cells represent an MΦ cell type with moderate phagocytic function. In these experiments, we gated on the CD209 + cells to identify MΦ. The MΦ induced by IL-1b demonstrated potent pinocytotic activity, as shown by uptake of Lucifer yellow (Fig. 3a) . Even though IL-1b-induced MΦ showed the highest MFI for Lucifer yellow uptake (1Á4-fold higher than the TLR2/1L-induced MΦ), the percentage of positive cells was equivalent for the different MΦ. To test for phagocytosis activity, we examined the uptake of oxLDL and mycobacteria BCG. The MFI for the uptake of oxLDL was highest in IL-1b-induced MΦ (1Á7-fold higher than TLR2/1L induced MΦ) but no difference in the percentage positive cells was observed (Fig. 3b) . Finally, the uptake of live mycobacteria, BCG, showed the highest MFI for the IL-1b-induced MΦ (1Á7-fold higher than the TLR2/ 1L-induced MΦ and equivalent to IL-15 MΦ) but no significant difference in the percentage positive cells (Fig. 3c) . To evaluate the ability of the cytokine-derived MΦ to bind particles or mycobacteria before uptake, MΦ were incubated as for the phagocytosis assays but at 4°instead of 37°. 1, 11 The binding capacity did not vary between the different MΦ (see Supplementary material, Fig. S3 ). Therefore, our data suggest that the IL-1b-induced MΦ display the phenotypic and functional characteristics of MΦ with both pinocytic and phagocytic activity.
IL-1b-induced MΦ are more potent antigenpresenting cells than TLR2/1L-induced MΦ
Given that IL-1b-induced MΦ express higher levels of the antigen-presenting molecule HLA-DR, compared with TLR2/1L-induced MΦ, we tested differentiated MΦ for their potential to process and present antigen, by immunomagnetic selection of CD209 + cells. For these experiments, we used the CD4 + , MHC class II-restricted T-cell clone, which recognizes an epitope from the M. leprae 10 000 molecular weight GroES protein. 12 As a control we used GM-CSF-induced CD1b + DC, enriched by immunomagnetic selection, known to be potent antigenpresenting cells for the GroES protein. 1 Using the GroES protein, IL-1b-derived MΦ induced up to 4Á3-fold higher T-cell proliferation than the TLR2/1L-induced MΦ. In addition, IL-1b-derived MΦ, at the concentrations of 2 9 10 4 and 4 9 10 4 cells/well, induced significantly higher IFN-c production, approximately twofold higher than the TLR2/1L-derived MΦ, but less than GM-CSFderived DC (Fig. 4) . Together these data suggest that the 
Discussion
The innate immune programmes that regulate phagocytosis and antigen presentation are believed to be distinct and independent, and characterize MΦ and DC, respectively. By comparing the role of IL-1b with that of TLR2/1L in innate immune programming, we found that in addition to inducing monocytes to differentiate into CD1b + DC, 3 IL-1b also triggers monocytes to rapidly differentiate into CD209 + MΦ. The IL-1b-derived CD209 + MΦ showed phagocytic activity similar to TLR2/1L-and IL-15-derived MΦ, including the ability to take up live mycobacteria. In addition, IL-1b-derived CD209 + MΦ were more efficient at processing and presenting mycobacterial antigen to MHC class II-restricted CD4 + T cells, albeit not as efficient as GM-CSF-derived DC. Although IL-1b and TLR2/ 1L activate cells via MyD88, they do not trigger identical signalling pathways. 5 Therefore, the ability of IL-1b to trigger the differentiation of a functionally distinct subset of CD209 + MΦ provides a distinct mechanism by which the innate immune system instructs the adaptive immune response against microbial pathogens. The identification that IL-1b by itself induces MΦ with enhanced antigenpresenting function is a first step in understanding the contribution of this pathway in the context of a complex mixture of immune stimuli. A key finding of the present study was that IL-1b triggered the differentiation of monocytes into CD209 + MΦ with both classical phagocytic activity and the ability to efficiently process and present antigen via MHC class II to T cells. Hence, IL-1b-derived CD209 + MΦ are part of a family of MΦ with antigen-presenting function, including those derived by priming with IFN-c and stimulating with either lipopolysaccharide alone or lipopolysaccharide plus immune complexes. 13, 14 The combined phagocytosis and antigen-presenting function of the IL-1b-induced CD209 + MΦ provides the innate immune system with the ability to simultaneously take up microbial pathogens and efficiently present them to T cells. In this context, the ability of IL-1b to also induce CD1b + DC, 3 which can present non-classical MHC antigens to T cells, provides a parallel pathway by which the innate immune system instructs the adaptive immune response.
The ability of IL-1b-derived CD209 + MΦ to activate T cells that produce IFN-c is also relevant for host defence against mycobacterial infection. IFN-c is prominent in the skin lesions of patients with the self-limited tuberculoid form versus the disseminated lepromatous form of leprosy, 15, 16 and the administration of IFN-c to patients with lepromatous leprosy transiently reduces the number of bacilli in lesions. 17 Levels of IFN-c are also increased in tuberculosis pleuritis, a self-curing form of tuberculosis. 18 Although previous studies indicated that IFN-c does not activate human MΦ to kill intracellular M. tuberculosis, recently it was shown that IFN-c activates the vitamin D pathway in human MΦ resulting in a significant antimicrobial activity. 19 The expression of CD209 on IL-1b-derived MΦ with both phagocytic and antigen-presenting function is probably relevant for the role of these cells in mycobacterial infection. Initially, CD209 was found to be expressed on DC in vitro, derived in the presence of GM-CSF and IL-4, 20 shown to be induced by IL-4. 21 However, it was subsequently reported that CD209 was not present on DC in vivo, but instead was a marker for tissue MΦ, 1 particularly specialized MΦ localized in the lymph node and at sites of inflammation. [22] [23] [24] [25] The expression of CD209 on MΦ derived from monocytes via TLR activation 1 or by culture with various cytokines including IL-15, 1,11 is required for the ability of these MΦ to bind and phagocytose mycobacteria, including M. leprae.
26 CD209 + MΦ are also prominent at the site of disease in tuberculosis 27 and leprosy. 1 Previous studies report that a single nucleotide polymorphism (À336A/G) in the CD209 promoter diminishes expression and is associated with human susceptibility to tuberculosis. 28, 29 In particular, CD209 expression is protective against cavitary tuberculosis.
28 CD209 expression, and hence CD209 + MΦ, has also been implicated in host defence against HIV and Dengue virus infection. 30, 31 In our work we used CD209 as macrophage marker, however its involvement in binding and subsequent uptake of mycobacteria has been previously shown. 1 A role for IL-1b in host defence against mycobacterial infection has been suggested by the demonstration that in human leprosy, IL-1b is more strongly expressed in lesions from patients with the self-limited tuberculoid form versus the disseminated lepromatous form of leprosy 15 and participates at the site of disease in tuberculosis. 32 A high IL-1b/low IL-1RA-producing haplotype has been associated with pleural tuberculosis, a form of the disease that generally resolves without chemotherapy. 33 Furthermore, mouse studies suggest an important role of IL-1b in tuberculosis: IL-1a and IL-1b double-knockout mice and IL-1R type I-deficient mice (which do not respond to IL-1) display an increased mycobacterial growth and also defective granuloma formation after infection with M. tuberculosis. 34, 35 In humans, IL-b has been shown to contribute to monocyte/MΦ antimicrobial activity against M. tuberculosis via induction of antimicrobial peptides 36 as well as via induction of caspase 3.
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Together, these data suggest the possibility of targeting the IL-1b MΦ pathway as an adjunct to therapy for advanced or drug-resistant mycobacterial infection, to induce an antimicrobial response as well as CD209 + MΦ with phagocytic and antigen-presenting function.
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